Overcoming the Phage Replication Threshold: a Mathematical Model with Implications for Phage Therapy

ABSTRACT Prior observations of phage-host systems in vitro have led to the conclusion that susceptible host cell populations must reach a critical density before phage replication can occur. Such a replication threshold density would have broad implications for the therapeutic use of phage. In this report, we demonstrate experimentally that no such replication threshold exists and explain the previous data used to support the existence of the threshold in terms of a classical model of the kinetics of colloidal particle interactions in solution. This result leads us to conclude that the frequently used measure of multiplicity of infection (MOI), computed as the ratio of the number of phage to the number of cells, is generally inappropriate for situations in which cell concentrations are less than 107/ml. In its place, we propose an alternative measure, MOIactual, that takes into account the cell concentration and adsorption time. Properties of this function are elucidated that explain the demonstrated usefulness of MOI at high cell densities, as well as some unexpected consequences at low concentrations. In addition, the concept of MOIactual allows us to write simple formulas for computing practical quantities, such as the number of phage sufficient to infect 99.99% of host cells at arbitrary concentrations.

[1]  D. Pratt,et al.  SOME PHYSICAL-CHEMICAL AND BIOLOGICAL PROPERTIES OF THE ROD-SHAPED COLIPHAGE M13. , 1964, Virology.

[2]  J. Norris,et al.  Prokaryotic gene therapy to combat multidrug resistant bacterial infection , 2000, Gene Therapy.

[3]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[4]  V. Jansen,et al.  Understanding bacteriophage therapy as a density-dependent kinetic process. , 2001, Journal of theoretical biology.

[5]  D. Pratt,et al.  THE INITIAL STEPS IN INFECTION WITH COLIPHAGE M13. , 1964, Virology.

[6]  B. Müller-Hill,et al.  Filamentous coliphage M13 as a cloning vehicle: insertion of a HindII fragment of the lac regulatory region in M13 replicative form in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Rosner Formation, induction, and curing of bacteriophage P1 lysogens. , 1972, Virology.

[8]  T. Lavery,et al.  Erratum in print version of "Toward a More Accurate Quantitation of the Activity of Recombinant Retroviruses: Alternatives to Titer and Multiplicity of Infection" , 2000, Journal of Virology.

[9]  L. Caro,et al.  The attachment of the male-specific bacteriophage F1 to sensitive strains of Escherichia coli. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Jansen,et al.  Phage therapy: The peculiar kinetics of self‐replicating pharmaceuticals , 2000, Clinical pharmacology and therapeutics.

[11]  B. Iglewski,et al.  Bacterial Quorum Sensing in Pathogenic Relationships , 2000, Infection and Immunity.

[12]  R. Tompkins,et al.  Retrovirus infection: effect of time and target cell number , 1995, Journal of virology.

[13]  A. Allison,et al.  Virus particle adsorption. I. Theory of adsorption and experiments on the attachment of particles to non-biological surfaces. , 1959, Biochimica et biophysica acta.

[14]  M. Alexander,et al.  Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems , 1985, Applied and environmental microbiology.

[15]  A. Allison,et al.  Virus particle adsorption. II. Adsorption of vaccinia and fowl plague viruses to cells in suspension. , 1960, Biochimica et biophysica acta.

[16]  G. Stent Molecular Biology of Bacterial Viruses , 1963 .